NEW YORK (GenomeWeb) – Purigen Biosystems said today that it has raised $18.2 million in a Series A financing round, and plans to use the funds to further develop and commercialize its technology for automated preparation of genomic and genetic testing samples.

The round was led by 5AM Ventures and Roche Venture Fund, the company said, with participation from existing investors the Stanford-Startx Fund and Western Investments Capital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.